Norwalk, Connecticut-based medication adherence platform company HealthPrize says it has succeeded in raising medication adherence an average of 54 percent across a series of pharma-sponsored pilot programs for various medical conditions, with sample sizes ranging from 250 to more than 7,000. That's a 54 percent increase in the mean total number of prescription fills per patient.
HealthPrize,...
Exco InTouch, the clinical trial technology vendor best known for its large-scale COPD program with AstraZeneca and the NHS trusts in England, has raised $5 million (3.2 million pounds). The round was led by Albion Ventures, according to British news site HealthInvestor. Scottish Equity Partners, Exco's largest shareholder, also contributed to the round.
The Nottingham, England-based company...
Pleasanton, California-based Spirometrix, a company working on a breath analysis sensor for early detection and treatment of asthma and COPD, has raised $8.6 million in second round funding. The round was led by NGK Spark Plugs, a Japanese company that manufactures spark plugs and oxygen sensors, which contributed $5 million. Existing investor Simul Investments also contributed. The raise brings...
Philips has unveiled a prototype system, consisting of a wearable sensor and connected software suite, to monitor patients with chronic obstructive pulmonary disease, or COPD. Philips worked with Radboud University Medical Center in the Netherlands to develop the system.
The sensor used to demo the prototype was the FDA-cleared HealthPatch sensor from Vital Connect, a peel and stick device that...
CoheroHealth, a New York City-based startup working on medication adherence tracking for asthma inhalers, is launching a small pilot with Mount Sinai Medical Center. The company will test its platform, which includes an inhaler sensor, a mobile app, and a connected spirometer, on 50 pediatric asthma patients.
"There are 50 million patients with respiratory disease and it costs $80 billion per...
Boehringer Ingelheim is a pretty familiar name to people who follow mobile health moves from pharma companies. The large, privately-owned German firm has been involved in pilots with game developer Ayogo, smart pill bottle maker AdhereTech, and now-defunct behavior change platform Healthrageous.
While its partners have talked up these pilots, up until now the company itself has been pretty quiet...
In the latest update to the iOS 8 beta, Apple added a number of health-related features, according to various reports. Most notably, the company added a data tracking capability for spirometry, which is data about how obstructed the lungs are collected by people with conditions like asthma or COPD.
Apple announced its Health app and HealthKit developer package at its WWDC event in June. The app...
Washington, DC-based modus health, a spin-off of a prosthesis company called Orthocare Innovations, has launched with the goal of creating a wearable activity tracker for clinical use. The technology is building on a research device called StepWatch that Orthocare has been using for some time.
"It’s sort of a wearable [that was created] before wearables were cool and it is a validated wearable...
A little over a year after completing a pilot study, pharmaceutical company AstraZeneca and Exco InTouch have launched a mobile-enabled program in the UK to help patients manage their chronic obstructive pulmonary disease (COPD), called Me&MyCOPD.
The program has three components -- a portal in which patients can connect with providers, a server on which information is saved and messages are...
New Zealand-based medical device company Nexus6 has received FDA clearance for its smartphone-connected inhaler, SmartTouch, as a class II medical device. The new SmartTouch device has been cleared as a prescribable Metered Dose Inhaler (MDI) with a handful of intended uses: in clinical trials; in clinical practice, and for patient self-management.
In all cases the device is used to help track...
